Common Sensing kicks off clinical study of connected insulin pen caps to track dosing
Sanofi and Dexcom are partnering with connected device startup Common Sensing in a clinical study to assess the performance of its insulin dosing technology.
Sanofi and Dexcom are partnering with connected device startup Common Sensing in a clinical study to assess the performance of its insulin dosing technology.